Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AVIR Green Hills Biotechnology commences deltaFLU Phase II study

AVIR Green Hills Biotechnology, the innovative biotech company based in Vienna, has started the New Year by embarking on the first clinical phase II study for the seasonal vaccine deltaFLU. The study will be carried out at the Medical University of Vienna. With this step, AVIR Green Hills has set yet another important milestone in the development of effective and modern influenza vaccines.

18 Jan 2010

WHO official rejects claims agency overhyped threat of H1N1

Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports.

18 Jan 2010

Shionogi receives approval to develop and commercialize intravenous peramivir in Japan

BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has received marketing and manufacturing approval for intravenous (i.v.) peramivir to treat patients with influenza in Japan.

13 Jan 2010

Whitley urges public to get vaccinated against H1N1 influenza virus

With several months left in the influenza season and growing supplies of vaccine, now is an opportune time to get vaccinated against the 2009 H1N1 influenza virus, says Richard Whitley, M.D., director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases and current president of the Infectious Diseases Society of America (IDSA).

13 Jan 2010

New genetic evidence can improve avian influenza surveillance programs

Genetic analyses of avian influenza in wild birds can help pinpoint likely carrier species and geographic hot spots where Eurasian viruses would be most likely to enter North America, according to new U.S. Geological Survey research.

13 Jan 2010

Massage Heights Houston opens new retreat in Royal Oaks area of Houston

Just in time for one of the most romantic holidays for couples -- Valentine's Day -- Massage Heights Houston opened its 11th Houston location on December 18th, 2009 in the Royal Oaks area of Houston.

13 Jan 2010

Record-breaking 8,300 health care professionals participate in online H1N1 vaccination education program

A record-breaking 8,300 front-line health care professionals participated in an accredited, online education program about H1N1 vaccination in November 2009 alone.

13 Jan 2010

Study recommends improvements for scaling up child survival programs

New child survival programs must engage evaluation teams from the start to identify the major causes of child mortality in intervention areas and to ensure that appropriate resources are available to scale up coverage and treatment, according to a retrospective evaluation led by researchers at the Johns Hopkins Bloomberg School of Public Health.

13 Jan 2010

Send Word Now to provide emergency voice and text communication services to Unity Health System's hospitals

Send Word Now, the leading provider of emergency notification and on-demand alerting and response services, announced today that Unity Health System, a 681-bed health-care network based out of Rochester, New York, has selected Send Word Now to provide emergency voice and text communication services to its hospitals.

13 Jan 2010

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

moksha8 and BioCryst today announced that moksha8 has been granted approval from COFEPRIS (The Federal Commission for the Protection against Sanitary Risk) in Mexico for the importation and use of peramivir in patients with influenza associated with the 2009 H1N1 influenza A strain.

13 Jan 2010

UNICEF program aimed at curbing deaths in West Africa falls short of goals, study finds

A $27 million UNICEF program that aims to decrease disease-related child deaths in West Africa did not meet its goal of reducing death rates by at least 25 percent at the conclusion of 2006, according to a Lancet study published on Tuesday, the Associated Press reports.

13 Jan 2010

Studies suggest ways to prevent post-surgical infections in hospitals

Two new studies are suggesting relatively simple ways in which hospitals can prevent many post-surgical infections by killing bacteria the patients themselves bring in, according to Monday's New York Times.

13 Jan 2010

ETMC Athens gears up for next flu pandemic

Throughout the month of September, East Texas Medical Center, Athens (ETMC Athens) saw a 42% average surge in number of patients per day due to publicity of the H1N1 virus and took it in stride. Improved efficiencies in the Emergency Department facilitated by a process improvement firm, Compirion Healthcare, allowed the hospital to absorb the volume and still see an improvement in quality.

13 Jan 2010

Pediatric specialists and pharmacists may get boost from health bills

News outlets report on how the health care bill pending in Congress might affect pediatric specialists and pharmacists.

13 Jan 2010

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

Novavax, Inc. announced today that it has successfully completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats. Results from this study are needed to support an Investigational New Drug (IND) application to advance this novel recombinant F protein particle based RSV (RSV-F) vaccine candidate into clinical development. This vaccine candidate is composed of recombinant 'F' or 'fusion' protein of RSV which is used by the virus to infect and fuse with cells in the respiratory tract and cause disease.

13 Jan 2010

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma - a vaccine surplus, the Associated Press reports.

12 Jan 2010

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

VaxInnate Corporation today announced that it has granted Indian biopharmaceutical company Biological E. Limited a license to its recombinant H1N1 pandemic swine flu vaccine and is collaborating to facilitate the manufacture, clinical development and commercialization of the vaccine in India.

12 Jan 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AVIR Green Hills Biotechnology commences deltaFLU Phase II study

WHO official rejects claims agency overhyped threat of H1N1

Shionogi receives approval to develop and commercialize intravenous peramivir in Japan

Whitley urges public to get vaccinated against H1N1 influenza virus

New genetic evidence can improve avian influenza surveillance programs

Massage Heights Houston opens new retreat in Royal Oaks area of Houston

Record-breaking 8,300 health care professionals participate in online H1N1 vaccination education program

Study recommends improvements for scaling up child survival programs

Send Word Now to provide emergency voice and text communication services to Unity Health System's hospitals

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

UNICEF program aimed at curbing deaths in West Africa falls short of goals, study finds

Studies suggest ways to prevent post-surgical infections in hospitals

ETMC Athens gears up for next flu pandemic

Pediatric specialists and pharmacists may get boost from health bills

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

Life Technologies to acquire AcroMetrix

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

Department of Health vaccinates 49,078 Pennsylvanians at 33 H1N1 flu clinics

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in